Research ArticleOriginal Article
Open Access

Safety and efficacy of intraoperative radiation therapy using a low-energy X-ray source for resectable pancreatic cancer: an interim evaluation of an ongoing prospective phase II study

Xingyun Chen, Shuo Li, Chuntao Gao, Wei Wang, Haorui Li, Yuxiao Liu, Rui Liu and Jihui Hao
Cancer Biology & Medicine January 2025, 22 (1) 67-76; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0287

References

  1. 1.↵
    2. Siegel RL,
    3. Giaquinto AN,
    4. Jemal A.
    Cancer statistics, 2024. CA Cancer J Clin. 2024; 74: 12–49.
    OpenUrlCrossRefPubMed
  2. 2.↵
    2. Baliyan V,
    3. Kordbacheh H,
    4. Parakh A,
    5. Kambadakone A.
    Response assessment in pancreatic ductal adenocarcinoma: role of imaging. Abdom Radiol (NY). 2018; 43: 435–44.
    OpenUrlPubMed
  3. 3.↵
    2. Teng T,
    3. Shi H,
    4. Fan Y,
    5. Guo P,
    6. Zhang J,
    7. Qiu X, et al.
    Metabolic responses to the occurrence and chemotherapy of pancreatic cancer: biomarker identification and prognosis prediction. Sci Rep. 2024; 14: 6938.
    OpenUrlPubMed
  4. 4.↵
    2. Smeenk HG,
    3. Tran TC,
    4. Erdmann J,
    5. van Eijck CH,
    6. Jeekel J.
    Survival after surgical management of pancreatic adenocarcinoma: does curative and radical surgery truly exist? Langenbecks Arch Surg. 2005; 390: 94–103.
    OpenUrlCrossRefPubMed
  5. 5.↵
    2. Iacobuzio-Donahue CA,
    3. Fu B,
    4. Yachida S,
    5. Luo M,
    6. Abe H,
    7. Henderson CM, et al.
    DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol. 2009; 27: 1806–13.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    2. Willett CG,
    3. Czito BG,
    4. Tyler DS.
    Intraoperative radiation therapy. J Clin Oncol. 2007; 25: 971–7.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    2. Ren H,
    3. Zhang JW,
    4. Lan ZM,
    5. Du YX,
    6. Qiu GT,
    7. Zhang LP, et al.
    Intraoperative radiotherapy vs concurrent chemoradiotherapy in the treatment of patients with locally advanced pancreatic cancer. Pancreatology. 2021; 21: 1052–8.
    OpenUrl
  8. 8.↵
    2. Cai S,
    3. Hong TS,
    4. Goldberg SI,
    5. Fernandez-del Castillo C,
    6. Thayer SP,
    7. Ferrone CR, et al.
    Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010. Cancer. 2013; 119: 4196–204.
    OpenUrlPubMed
  9. 9.↵
    2. Reni M,
    3. Panucci MG,
    4. Ferreri AJ,
    5. Balzano G,
    6. Passoni P,
    7. Cattaneo GM, et al.
    Effect on local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys. 2001; 50: 651–8.
    OpenUrlPubMed
  10. 10.
    2. Coia LR,
    3. Hanks GE.
    The need for subspecialization: intraoperative radiation therapy. Int J Radiat Oncol Biol Phys. 1992; 24: 891–3.
    OpenUrlPubMed
  11. 11.
    2. Mohiuddin M,
    3. Regine WF,
    4. Stevens J,
    5. Rosato F,
    6. Barbot D,
    7. Biermann W, et al.
    Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas. J Clinl Oncol. 1995; 13: 2764–8.
    OpenUrl
  12. 12.
    2. Ogawa K,
    3. Karasawa K,
    4. Ito Y,
    5. Ogawa Y,
    6. Jingu K,
    7. Onishi H, et al.
    Intraoperative radiotherapy for unresectable pancreatic cancer: a multi-institutional retrospective analysis of 144 patients. Int J Radiat Oncol Biol Phys. 2011; 80: 111–8.
    OpenUrlPubMed
  13. 13.↵
    2. Chen Y,
    3. Che X,
    4. Zhang J,
    5. Huang H,
    6. Zhao D,
    7. Tian Y, et al.
    Long-term results of intraoperative electron beam radiation therapy for nonmetastatic locally advanced pancreatic cancer: retrospective cohort study, 7-year experience with 247 patients at the National Cancer Center in China. Medicine (Baltimore). 2016; 95: e4861.
  14. 14.↵
    2. Palta M,
    3. Willett C,
    4. Czito B.
    The role of intraoperative radiation therapy in patients with pancreatic cancer. Semin Radiat Oncol. 2014; 24: 126–31.
    OpenUrlPubMed
  15. 15.↵
    2. Jin L,
    3. Shi N,
    4. Ruan S,
    5. Hou B,
    6. Zou Y,
    7. Zou X, et al.
    The role of intraoperative radiation therapy in resectable pancreatic cancer: a systematic review and meta-analysis. Radiat Oncol. 2020; 15: 76.
    OpenUrlPubMed
  16. 16.↵
    2. Jingu K,
    3. Tanabe T,
    4. Nemoto K,
    5. Ariga H,
    6. Umezawa R,
    7. Ogawa Y, et al.
    Intraoperative radiotherapy for pancreatic cancer: 30-year experience in a single institution in Japan. Int J Radiat Oncol Biol Phys. 2012; 83: e507–11.
    OpenUrlPubMed
  17. 17.↵
    2. Ashman JB,
    3. Moss AA,
    4. Rule WG,
    5. Callister MG,
    6. Reddy KS,
    7. Mulligan DC, et al.
    Preoperative chemoradiation and IOERT for unresectable or borderline resectable pancreas cancer. J Gastrointest Oncol. 2013; 4: 352–60.
    OpenUrlPubMed
  18. 18.↵
    2. Calvo FA,
    3. Meirino RM,
    4. Orecchia R.
    Intraoperative radiation therapy first part: rationale and techniques. Crit Rev Oncol Hematol. 2006; 59: 106–15.
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    2. Schneider F,
    3. Bludau F,
    4. Clausen S,
    5. Fleckenstein J,
    6. Obertacke U,
    7. Wenz F.
    Precision IORT – image guided intraoperative radiation therapy (igIORT) using online treatment planning including tissue heterogeneity correction. Phys Med. 2017; 37: 82–7.
    OpenUrlPubMed
  20. 20.↵
    National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma (Version 2.2024) http://www.nccn.org.
  21. 21.↵
    2. Paiella S,
    3. Malleo G,
    4. Simoni N,
    5. Micera R,
    6. Guariglia S,
    7. Cavedon C, et al.
    A phase II trial proposal of total neoadjuvant treatment with primary chemotherapy, stereotactic body radiation therapy, and intraoperative radiation therapy in borderline resectable pancreatic adenocarcinoma. BMC Cancer. 2021; 21: 165.
    OpenUrlPubMed
  22. 22.↵
    2. Cardillo N,
    3. Seible DM,
    4. Fero KE,
    5. Bruggeman AR,
    6. Sarkar RR,
    7. Azuara A, et al.
    Clinical impact of local progression in pancreatic cancer. J Natl Compr Canc Netw. 2018; 16: 711–7.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    2. Zerbi A,
    3. Fossati V,
    4. Parolini D,
    5. Carlucci M,
    6. Balzano G,
    7. Bordogna G, et al.
    Intraoperative radiation therapy adjuvant to resection in the treatment of pancreatic cancer. Cancer. 1994; 73: 2930–5.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    2. Dobelbower RR,
    3. Merrick HW,
    4. Khuder S,
    5. Battle JA,
    6. Herron LM,
    7. Pawlicki T.
    Adjuvant radiation therapy for pancreatic cancer: a 15-year experience. Int J Radiat Oncol Biol Phys. 1997; 39: 31–7.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.
    2. Kokubo M,
    3. Nishimura Y,
    4. Shibamoto Y,
    5. Sasai K,
    6. Kanamori S,
    7. Hosotani R, et al.
    Analysis of the clinical benefit of intraoperative radiotherapy in patients undergoing macroscopically curative resection for pancreatic cancer. Int J Radiat Oncol Biol Phys. 2000; 48: 1081–7.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.
    2. Ihse I,
    3. Andersson R,
    4. Ask A,
    5. Ewers S,
    6. Lindell G,
    7. Tranberg KG.
    Intraoperative radiotherapy for patients with carcinoma of the pancreas. Pancreatology. 2005; 5: 438–42.
    OpenUrlPubMed
  27. 27.↵
    2. Takamori H,
    3. Hiraoka T,
    4. Kanemitsu K,
    5. Tsuji T,
    6. Tanaka H,
    7. Chikamoto A, et al.
    Long-term outcomes of extended radical resection combined with intraoperative radiation therapy for pancreatic cancer. J Hepatobiliary Pancreat Surg. 2008; 15: 603–7.
    OpenUrlPubMed
  28. 28.↵
    2. Cai W,
    3. Zhu Y,
    4. Teng Z,
    5. Li D,
    6. Feng Q,
    7. Jiang Z, et al.
    Combined CT and serum CA19-9 for stratifying risk for progression in patients with locally advanced pancreatic cancer receiving intraoperative radiotherapy. Front Oncol. 2023; 13: 1155555.
  29. 29.↵
    2. Ogawa K,
    3. Karasawa K,
    4. Ito Y,
    5. Ogawa Y,
    6. Jingu K,
    7. Onishi H, et al.
    Intraoperative radiotherapy for resected pancreatic cancer: a multi-institutional retrospective analysis of 210 patients. Int J Radiat Oncol Biol Phys. 2010; 77: 734–42.
    OpenUrlPubMed
  30. 30.↵
    2. Wu L,
    3. Huang P,
    4. Wang F,
    5. Li D,
    6. Xie E,
    7. Zhang Y, et al.
    Relationship between serum CA19-9 and CEA levels and prognosis of pancreatic cancer. Ann Transl Med. 2015; 3: 328.
    OpenUrlPubMed
  31. 31.
    2. Nagai M,
    3. Nakamura K,
    4. Terai T,
    5. Kohara Y,
    6. Yasuda S,
    7. Matsuo Y, et al.
    Significance of multiple tumor markers measurements in conversion surgery for unresectable locally advanced pancreatic cancer. Pancreatology. 2023; 23: 721–8.
    OpenUrlPubMed
  32. 32.↵
    2. Sato A,
    3. Masui T,
    4. Kaneda A,
    5. Yogo A,
    6. Uchida Y,
    7. Anazawa T, et al.
    Association between patient’s age and the utility of prognostic markers after pancreaticoduodenectomy for pancreatic cancer. Asian J Surg. 2023; 46: 3052–7.
    OpenUrlPubMed
  33. 33.↵
    2. Peng L,
    3. Chen H.
    A novel nomogram and risk classification system based on inflammatory and immune indicators for predicting prognosis of pancreatic cancer patients with liver metastases. Cancer Med. 2023; 12: 18622–32.
    OpenUrlPubMed
  34. 34.↵
    2. Otsu T,
    3. Hayashi M,
    4. Takami H,
    5. Inokawa Y,
    6. Tanaka N,
    7. Kurimoto K, et al.
    High preoperative serum D-dimer predicts unfavorable survival outcomes for pancreatic cancer patients. Anticancer Res. 2023; 43: 3173–81.
    OpenUrlAbstract/FREE Full Text
  35. 35.↵
    2. Wu B,
    3. Zhang G,
    4. Zhao X,
    5. Wang J,
    6. Wang D,
    7. Zhang Y, et al.
    Association between D-dimer levels and clinicopathological characteristics of pancreatic cancer and its role in prognosis: a systematic review and meta-analysis. Asian J Surg. 2024; 47: 3417–24.
    OpenUrlPubMed
  36. 36.↵
    2. Hibino S,
    3. Kawazoe T,
    4. Kasahara H,
    5. Itoh S,
    6. Ishimoto T,
    7. Sakata-Yanagimoto M, et al.
    Inflammation-induced tumorigenesis and metastasis. Int J Mol Sci. 2021; 22: 5421.
    OpenUrlPubMed
  37. 37.↵
    2. Lee YS,
    3. Kim HS,
    4. Cho Y,
    5. Lee IJ,
    6. Kim HJ,
    7. Lee DE, et al.
    Intraoperative radiation therapy induces immune response activity after pancreatic surgery. BMC Cancer. 2021; 21: 1097.
    OpenUrlPubMed
  38. 38.↵
    2. Roeder F,
    3. Fastner G,
    4. Fussl C,
    5. Sedlmayer F,
    6. Stana M,
    7. Berchtold J, et al.
    First clinical application of image-guided intraoperative electron radiation therapy with real time intraoperative dose calculation in recurrent rectal cancer: technical procedure. Radiat Oncol. 2023; 18: 186.
    OpenUrlPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Subjects

Keywords